ATRC

SEC source: 0001323885-25-000018 · wk-form4_1741125580.xml · nonDerivative · entry 3

Wirick Angela L · CIK 0001819885 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,770

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

SEC source: 0001323885-25-000018 · wk-form4_1741125580.xml · nonDerivative · entry 2

Wirick Angela L · CIK 0001819885 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,403

F2 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.

SEC source: 0001323885-25-000018 · wk-form4_1741125580.xml · nonDerivative · entry 1

Wirick Angela L · CIK 0001819885 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 169,400

F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

SEC source: 0001323885-25-000022 · wk-form4_1741125634.xml · nonDerivative · entry 3

Noznesky Justin J · CIK 0001666600 · Chief Mktg & Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,964

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

SEC source: 0001323885-25-000022 · wk-form4_1741125634.xml · nonDerivative · entry 2

Noznesky Justin J · CIK 0001666600 · Chief Mktg & Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,637

F2 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.

SEC source: 0001323885-25-000022 · wk-form4_1741125634.xml · nonDerivative · entry 1

Noznesky Justin J · CIK 0001666600 · Chief Mktg & Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,058

F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

SEC source: 0001323885-25-000021 · wk-form4_1741125615.xml · nonDerivative · entry 3

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 710,555

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

SEC source: 0001323885-25-000021 · wk-form4_1741125615.xml · nonDerivative · entry 2

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 754,481

F2 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.

SEC source: 0001323885-25-000021 · wk-form4_1741125615.xml · nonDerivative · entry 1

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 703,574

F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

SEC source: 0001323885-25-000025 · wk-form4_1741125669.xml · nonDerivative · entry 3

Seith Douglas J · CIK 0001565823 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 183,563

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

SEC source: 0001323885-25-000025 · wk-form4_1741125669.xml · nonDerivative · entry 2

Seith Douglas J · CIK 0001565823 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198,613

F2 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.

SEC source: 0001323885-25-000025 · wk-form4_1741125669.xml · nonDerivative · entry 1

Seith Douglas J · CIK 0001565823 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186,493

F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

SEC source: 0001323885-25-000024 · wk-form4_1741125658.xml · nonDerivative · entry 3

Privitera Salvatore · CIK 0001336063 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,765

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

SEC source: 0001323885-25-000024 · wk-form4_1741125658.xml · nonDerivative · entry 2

Privitera Salvatore · CIK 0001336063 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,162

F2 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.

SEC source: 0001323885-25-000024 · wk-form4_1741125658.xml · nonDerivative · entry 1

Privitera Salvatore · CIK 0001336063 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,583

F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

SEC source: 0001323885-25-000020 · wk-form4_1741125603.xml · nonDerivative · entry 2

Yount Deborah Lee · CIK 0001926195 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,578

F2 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

SEC source: 0001323885-25-000020 · wk-form4_1741125603.xml · nonDerivative · entry 1

Yount Deborah Lee · CIK 0001926195 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,539

F1 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.

SEC source: 0001323885-24-000119 · wk-form4_1734011301.xml · nonDerivative · entry 1

Noznesky Justin J · CIK 0001666600 · Chief Mktg & Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,699

F1 · price: No consideration was received in connection with this charitable gift.

SEC source: 0001323885-24-000110 · wk-form4_1724071555.xml · nonDerivative · entry 1

Yuen Maggie · CIK 0001796057 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,970

SEC source: 0001323885-24-000108 · wk-form4_1723812385.xml · nonDerivative · entry 1

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 653,239

F1 · price: No consideration was received in connection with this charitable gift.

SEC source: 0001323885-24-000097 · wk-form4_1719951914.xml · nonDerivative · entry 1

Doraiswamy Vinayak · CIK 0001862458 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,784

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2024.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 28, 2024, which is the last trading day of the applicable offering period. The closing price on June 28, 2024 was $22.77.

SEC source: 0001323885-24-000100 · wk-form4_1719951952.xml · nonDerivative · entry 1

Dahlquist Karl S. · CIK 0001861996 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,661

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2024.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 28, 2024, which is the last trading day of the applicable offering period. The closing price on June 28, 2024 was $22.77.

SEC source: 0001323885-24-000099 · wk-form4_1719951941.xml · nonDerivative · entry 1

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 656,239

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2024.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 28, 2024, which is the last trading day of the applicable offering period. The closing price on June 28, 2024 was $22.77.

SEC source: 0001323885-24-000101 · wk-form4_1719951964.xml · nonDerivative · entry 1

Seith Douglas J · CIK 0001565823 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,227

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2024.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 28, 2024, which is the last trading day of the applicable offering period. The closing price on June 28, 2024 was $22.77.

SEC source: 0001323885-24-000098 · wk-form4_1719951929.xml · nonDerivative · entry 1

Privitera Salvatore · CIK 0001336063 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,997

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2024.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 28, 2024, which is the last trading day of the applicable offering period. The closing price on June 28, 2024 was $22.77.

SEC source: 0001323885-24-000096 · wk-form4_1719951900.xml · nonDerivative · entry 1

Yount Deborah Lee · CIK 0001926195 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,926

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2024.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 28, 2024, which is the last trading day of the applicable offering period. The closing price on June 28, 2024 was $22.77.

SEC source: 0001323885-24-000112 · wk-form4_1726663825.xml · nonDerivative · entry 2

Yount Deborah Lee · CIK 0001926195 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,686

F1 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award.

SEC source: 0001323885-24-000087 · wk-form4_1717186344.xml · nonDerivative · entry 1

Privitera Salvatore · CIK 0001336063 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,290

SEC source: 0001323885-24-000077 · wk-form4_1715720619.xml · nonDerivative · entry 1

Nachman Shlomo · CIK 0002006261 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,110

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001323885-24-000080 · wk-form4_1715720687.xml · nonDerivative · entry 1

Telman Deborah H · CIK 0001860008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,783

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001323885-24-000082 · wk-form4_1715720728.xml · nonDerivative · entry 1

JOHNSON B KRISTINE · CIK 0001231984 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,409

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001323885-24-000079 · wk-form4_1715720668.xml · nonDerivative · entry 1

WEHRWEIN SVEN · CIK 0001205069 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,973

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001323885-24-000084 · wk-form4_1715720766.xml · nonDerivative · entry 1

WHITE ROBERT S. · CIK 0001571208 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,773

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001323885-24-000083 · wk-form4_1715720742.xml · nonDerivative · entry 1

Yuen Maggie · CIK 0001796057 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,470

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001323885-24-000081 · wk-form4_1715720715.xml · nonDerivative · entry 1

GROVES REGINA E · CIK 0001653877 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,766

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001323885-24-000078 · wk-form4_1715720654.xml · nonDerivative · entry 1

Prange Karen · CIK 0001566083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,928

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001323885-24-000064 · wk-form4_1714740653.xml · nonDerivative · entry 1

Noznesky Justin J · CIK 0001666600 · Chief Mktg & Strategy Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,284

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan adopted on December 12, 2023.

SEC source: 0001323885-24-000053 · wk-form4_1712148053.xml · nonDerivative · entry 1

Noznesky Justin J · CIK 0001666600 · Chief Mktg & Strategy Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 72,784

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan adopted on December 12, 2023.

SEC source: 0001323885-24-000046 · wk-form4_1710938484.xml · nonDerivative · entry 1

Dahlquist Karl S. · CIK 0001861996 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 50,954

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan adopted on February 24, 2023.

SEC source: 0001323885-24-000044 · wk-form4_1710766020.xml · nonDerivative · entry 1

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 655,532

F1 · price: No consideration was received in connection with this gift to the reporting person's children.

SEC source: 0001323885-24-000042 · wk-form4_1710420943.xml · nonDerivative · entry 1

Noznesky Justin J · CIK 0001666600 · Chief Mktg & Strategy Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,284

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan adopted on December 12, 2023.

SEC source: 0001323885-24-000040 · wk-form4_1709814482.xml · nonDerivative · entry 1

Dahlquist Karl S. · CIK 0001861996 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,839

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan adopted on February 24, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $36.57 to $37.74 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001323885-24-000033 · wk-form4_1709675052.xml · nonDerivative · entry 3

Doraiswamy Vinayak · CIK 0001862458 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,077

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

SEC source: 0001323885-24-000033 · wk-form4_1709675052.xml · nonDerivative · entry 2

Doraiswamy Vinayak · CIK 0001862458 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,932

F2 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.

SEC source: 0001323885-24-000033 · wk-form4_1709675052.xml · nonDerivative · entry 1

Doraiswamy Vinayak · CIK 0001862458 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,604

F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

SEC source: 0001323885-24-000035 · wk-form4_1709675103.xml · nonDerivative · entry 2

Dahlquist Karl S. · CIK 0001861996 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,070

F2 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.

SEC source: 0001323885-24-000035 · wk-form4_1709675103.xml · nonDerivative · entry 1

Dahlquist Karl S. · CIK 0001861996 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,839

F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

SEC source: 0001323885-24-000036 · wk-form4_1709675153.xml · derivative · entry 4

Wirick Angela L · CIK 0001819885 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Non-qualified Stock Option (right to buy) · 5,000 shares

Expires 2024-07-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted on July 28, 2014. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.

SEC source: 0001323885-24-000036 · wk-form4_1709675153.xml · nonDerivative · entry 3

Wirick Angela L · CIK 0001819885 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,070

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001323885-24-000036 · wk-form4_1709675153.xml · nonDerivative · entry 2

Wirick Angela L · CIK 0001819885 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,070

F2 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.